Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.
Liao W, Yu Q, Chen B, Chen H, Zou L, Xie H, Chen H, Wang C, Li Y, Gao X, Guo H, Yang Y, She Z, Zeng Q, Zhang Z, Li G, Feng S, Lin H, Ouyang J, Liang J, Ao W, Zeng Q, Liu Z, Weng H, Huang H, Zhu F, Liu R, Wang Y, Yu D, Li X, Mai Y, Jiang S, Tu Y, Li Z, Liu J; Alzheimer's Disease Neuroimaging Initiative.
Liao W, et al. Among authors: zhu f.
Alzheimers Dement. 2026 Mar;22(3):e71231. doi: 10.1002/alz.71231.
Alzheimers Dement. 2026.
PMID: 41823189